Taconic Biosciences News

Taconic Biosciences News is your source for current and relevant news on how animal models are being used to drive drug discovery. Use the links below to explore exciting announcements from Taconic via Press Releases, Taconic’s press coverage in Publications and Media, and critical scientific insights within Industry News.

Taconic Biosciences Changes to a New Set of Genotyping Codes

Hudson, New York — October 20, 2014 - As part of Taconic’s commitment to better serve its clients, we have decided to change the way we document our genotyping codes. Historically, Taconic has used a one-letter genotyping code to document mutated alleles. However, due to the increase in complexity of mutant allele types and the challenges of documenting them, Taconic has decided to replace its old genotyping...

Read More

Taconic Changes Legal Name to Taconic Biosciences

Hudson, NY — September 23, 2014 - Taconic announced today that it has changed the legal name of the company from Taconic Farms, Inc. to Taconic Biosciences, Inc. The change in Taconic’s name reflects the evolution of the firm from primarily a breeder of laboratory mice and rats to a science and technologies-based service company focused on providing genetically engineered models and services to biomedical and biopharmaceutical...

Read More

Enhanced IHMS Improves Testing Accuracy, Streamlines Reporting

Hudson, New York — August 19, 2014 - Taconic recently completed a comprehensive, year-long review of the IHMS to ensure it reflects current industry conditions and the needs of our customers. We have launched an updated version of our International Health Monitoring System (IHMS), a critical component of our rigorous quality program. These updates reflect changes in the prevalence of certain agents in lab animal settings and...

Read More

Taconic Announces New Agreement to Distribute Next Generation NOG Mouse Models

Hudson, New York — July 23, 2014 - Taconic announced that it has finalized a distribution and licensing agreement with the Central Institute for Experimental Animals (CIEA) and In-Vivo Science International Inc. (IVSI) that grants Taconic exclusive rights to commercialize up to thirty strains of next generation NOG mice models in the United States, Europe and Australia. The agreement also allows Taconic to perform human cell engraftment...

Read More

Taconic and CERBM-IGBMC collaborate to offer Cre-ERT Technology

Hudson, NY — July 10, 2014 - Taconic and Le Centre Européen de Recherche en Biologie et en Médecine – Institut de Génétique et de Biologie Moléculaire et Cellulaire (CERBM-IGBMC) announced a global cross-licensing agreement to improve access to Cre-ERT technology for inducible gene targeting in genetically engineered rodents. Under the agreement each party will be able to generate, sell and use Cre-ERT mouse lines for tamoxifen...

Read More

Dr. Robert J. Rosenthal Appointed Chief Executive Officer of Taconic

Hudson, New York — June 2, 2014 – Taconic announced today the appointment of Dr. Robert J. Rosenthal as Chief Executive Officer (CEO). Effective immediately, Dr. Rosenthal will succeed current interim CEO, Samuel Phelan who will focus exclusively on his ongoing role as Chairman of the Taconic Board of Directors. Dr. Rosenthal has over thirty years’ experience increasing shareholder value and managing scientific and technical companies. Immediately...

Read More

Taconic Launches CRISPR Gene Editing Technology

Hudson, New York — May 28, 2014 – Taconic announced that it has officially launched CRISPR gene editing technology after receiving a license under certain patents from The Broad Institute. The Broad Institute patent represents the first granted patent for use of CRISPR technology in eukaryotic cells and is based on work by Dr. Feng Zhang in a paper published in Science in 2013. CRISPR technology promises...

Read More

Taconic Launches Exciting New Website in Support of Translational Microbiome Research

Hudson, New York — May 1, 2014 – Taconic announced the launch of the Translational Microbiome Research Forum website, which provides an opportunity for investigators worldwide to access and exchange information in the emerging field of microbiome research. The Translational Microbiome Research Forum website provides up-to-date news, publications, events, and meetings about translational microbiome research. It is also a place to join a community of peers to...

Read More

Taconic and In Vitro ADMET Laboratories Announce Alliance to Offer Humanized and Knock-out Mouse Hepatocytes

Hudson, New York — March 20, 2014 - Taconic and In Vitro ADMET Laboratories, LLC (IVAL) announced an agreement today under which IVAL will prepare cryopreserved hepatocytes derived from Taconic’s knockout and genetically humanized mouse models for use in preclinical drug development research. The resulting plateable cryopreserved hepatocytes will be a commercial product available from either company. Using hepatocytes from Taconic’s translational mouse models, researchers can leverage...

Read More

Taconic and InVivos Announce Distribution Agreement in Singapore

Hudson, New York — December 12, 2013 - Taconic and InVivos Pte Ltd. announced today that the two organizations have signed an agreement in which Taconic has granted InVivos rights to market and distribute Taconic research models and services in Singapore. The agreement facilitates InVivos' efforts to provide researchers in Singapore with a wide variety of traditional and genetically engineered mouse and rat strains. Additionally, the agreement...

Read More